4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $495.71 million. The enterprise value is $3.09 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 51.05 million shares outstanding. The number of shares has increased by 7.39% in one year.
| Current Share Class | 51.05M |
| Shares Outstanding | 51.05M |
| Shares Change (YoY) | +7.39% |
| Shares Change (QoQ) | +13.88% |
| Owned by Insiders (%) | 3.64% |
| Owned by Institutions (%) | 78.54% |
| Float | 35.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.82 |
| Forward PS | 23.52 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.39, with a Debt / Equity ratio of 0.04.
| Current Ratio | 9.39 |
| Quick Ratio | 9.15 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.57% and return on invested capital (ROIC) is -18.40%.
| Return on Equity (ROE) | -27.57% |
| Return on Assets (ROA) | -17.34% |
| Return on Invested Capital (ROIC) | -18.40% |
| Return on Capital Employed (ROCE) | -29.91% |
| Weighted Average Cost of Capital (WACC) | 18.62% |
| Revenue Per Employee | $434,740 |
| Profits Per Employee | -$714,842 |
| Employee Count | 196 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +158.25% in the last 52 weeks. The beta is 2.76, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.76 |
| 52-Week Price Change | +158.25% |
| 50-Day Moving Average | 9.35 |
| 200-Day Moving Average | 8.70 |
| Relative Strength Index (RSI) | 53.24 |
| Average Volume (20 Days) | 677,057 |
Short Selling Information
The latest short interest is 11.52 million, so 22.56% of the outstanding shares have been sold short.
| Short Interest | 11.52M |
| Short Previous Month | 10.86M |
| Short % of Shares Out | 22.56% |
| Short % of Float | 32.67% |
| Short Ratio (days to cover) | 14.07 |
Income Statement
In the last 12 months, FDMT had revenue of $85.21 million and -$140.11 million in losses. Loss per share was -$2.42.
| Revenue | 85.21M |
| Gross Profit | -107.29M |
| Operating Income | -156.35M |
| Pretax Income | -140.11M |
| Net Income | -140.11M |
| EBITDA | -151.65M |
| EBIT | -156.35M |
| Loss Per Share | -$2.42 |
Full Income StatementBalance Sheet
The company has $402.66 million in cash and $21.41 million in debt, with a net cash position of $492.62 million or $9.65 per share.
| Cash & Cash Equivalents | 402.66M |
| Total Debt | 21.41M |
| Net Cash | 492.62M |
| Net Cash Per Share | $9.65 |
| Equity (Book Value) | 505.66M |
| Book Value Per Share | 8.78 |
| Working Capital | 369.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$109.08 million and capital expenditures -$536,000, giving a free cash flow of -$109.62 million.
| Operating Cash Flow | -109.08M |
| Capital Expenditures | -536,000 |
| Depreciation & Amortization | 4.69M |
| Net Borrowing | n/a |
| Free Cash Flow | -109.62M |
| FCF Per Share | -$2.15 |
Full Cash Flow StatementMargins
Gross margin is -125.91%, with operating and profit margins of -183.49% and -164.43%.
| Gross Margin | -125.91% |
| Operating Margin | -183.49% |
| Pretax Margin | -164.43% |
| Profit Margin | -164.43% |
| EBITDA Margin | -177.98% |
| EBIT Margin | -183.49% |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.39% |
| Shareholder Yield | -7.39% |
| Earnings Yield | -28.26% |
| FCF Yield | -22.11% |
Analyst Forecast
The average price target for FDMT is $31.71, which is 226.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.71 |
| Price Target Difference | 226.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 40.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 1.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 2 |
